Skip Navigation


NDT Advance Access originally published online on November 6, 2006
Nephrology Dialysis Transplantation 2007 22(1):23-25; doi:10.1093/ndt/gfl639
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow All Versions of this Article:
22/1/23    most recent
gfl639v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Shaldon, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Shaldon, S.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The Author [2006]. Published by Oxford University Press on behalf of ERA-EDTA. All rights reserved. For Permissions, please email: journals.permissions@oxfordjournals.org

The use of IV iron in the treatment of anaemia of ESRD patients on maintenance haemodialysis: an historical and personal view

Stanley Shaldon

25 Le Michelangelo, 7 Avenue des Papalins, Monaco, 98000

Correspondence and offprint requests to: Stanley Shaldon, MA, MD, FRCP, 25 Le Michelangelo, 7 Avenue des Papalins, Monaco, 98000. Email: stanley.shaldon@libello.com

Keywords: anaemia; erythropoietin; iron; serendipity

The first 10% of the full text of this article appears below.

Dr Schiesser and others have confirmed a well-reported phenomenon, that intravenous (IV) iron in apparently iron-replete patients will decrease the epoetin requirements for a given target haematocrit in patients on maintenance haemodialysis with end-stage renal disease (ESRD) [1]. The original description of a reduction in epoetin requirements by using IV iron in apparently iron-replete patients was first reported in 1993 [2] and the . . . [Full Text of this Article]


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?